about
Cyclin D1 expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat.Finding the needle in the haystack: why high-throughput screening is good for your health.Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.Inhibition of human breast cancer cell growth by blockade of the mevalonate-protein prenylation pathway is not prevented by overexpression of cyclin D1.Progesterone and breast cancer.Novel splice variants of cyclin E with altered substrate specificity.Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight formsSquamous carcinoma of the head and neck: molecular mechanisms and potential biomarkers.Role of phosphorylation in progesterone receptor signaling and specificityDormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas.Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.Genetic engineering to study testicular tumorigenesis.Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance.Association among the expression of β-catenin, cyclin D1 and estrogen receptor-β in human breast cancerPrognostic factors for breast cancer and their use in the clinical setting.Borealin is repressed in response to p53/Rb signaling.Challenges to defining a role for progesterone in breast cancer.Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatmentA Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cellsControl of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase.Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenasesNuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.Expression and sequence of canine SIRT2 and p53 genes in canine mammary tumour cells - effects on downstream targets Wip1 and p21/Cip1.Loss of androgen receptor transcriptional activity at the G(1)/S transition.Ectopic expression of Rsu-1 results in elevation of p21CIP and inhibits anchorage-independent growth of MCF7 breast cancer cells.Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression.Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer.Molecular targets for cell cycle inhibition and cancer therapy
P2860
Q24791191-273EEE37-A3DB-4A0F-88F1-80DC361B7C78Q24802613-2BA8B7B1-C5BC-45BF-A1A6-6958A4ED2646Q30442906-0CBCCCE9-24F7-4722-8C9D-783E2C0FCF52Q31957656-EB173455-DF77-470E-912A-749B31285AECQ33687459-2847CCA4-3A07-4F20-960F-4C64BD9533A8Q33855990-948DCC20-88FB-4C30-96E1-F84CCED5DB55Q33969505-98B15089-E68C-4DE1-9C8F-81A77B87D244Q34005879-5CD76957-956F-4CBD-B6C0-91A6EE670719Q34029956-CF9015DE-AF89-4F43-822B-0A994518E178Q34136905-23AD3A86-AF7C-41F6-B411-8B899270B986Q34278253-1EB2418D-A6FC-4C14-92B5-3B4DD37C13B6Q34940834-EEC3BF59-8C3C-4256-9141-9EC2C404931DQ35096710-7598DB99-800E-47E5-8026-10E4773891AEQ35132958-C30879D1-3046-47FE-B5B7-AACF12F47A42Q36076419-95480EC4-D01E-4FAB-8F82-C2316B7A2156Q36081340-45E368A9-791F-45A3-90D5-5B022BBF0EE8Q36118398-8E319BD5-58FE-4F6D-AD56-3E5C8E3F36FBQ36208599-D11C9F8D-86E2-4697-8C86-5BCA39694177Q36786766-AF4BD681-76F9-4318-AE14-EFC603EE8FD0Q37003317-A22FB3A7-8E46-4680-A122-8D17DA0558C1Q37236792-BBC83FE6-6D42-477F-969D-0783BFFFE383Q37459528-50BA6A5C-988E-4392-8795-01DE1049DF07Q37957006-1B2AD68B-9FE5-439B-B567-1C1E0D054EA7Q38310771-BF4E4D69-A8EF-4021-ABDA-BD669E8ECBBEQ40238081-397B5413-3EC2-4B1A-BFE9-B0F98FB4B3C1Q40726442-F02406B6-861F-4F11-B3AB-6F1A5D01C0E3Q40863839-4CF518CC-529C-42FF-A866-AF2A2E783918Q43709177-D3121089-61BC-4ADB-B690-C83820E606FBQ46823214-2D10CE74-A589-4811-92B9-40BF49475103Q47774103-FFA4DB98-3B58-49F8-821D-9EBCDB6BC229Q58884834-71E9E878-C7BB-4DCA-87CC-55C9CE2FD944
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Cyclins and breast cancer.
@ast
Cyclins and breast cancer.
@en
Cyclins and breast cancer.
@nl
type
label
Cyclins and breast cancer.
@ast
Cyclins and breast cancer.
@en
Cyclins and breast cancer.
@nl
prefLabel
Cyclins and breast cancer.
@ast
Cyclins and breast cancer.
@en
Cyclins and breast cancer.
@nl
P2860
P356
P1476
Cyclins and breast cancer.
@en
P2860
P2888
P356
10.1023/A:1006102916060
P407
P577
1998-01-01T00:00:00Z
P5875
P6179
1038268859